LEP and chronic kidney disease: These results suggest that in CKD patients, (a) an increase in leptin synthesis takes place in the adipose tissue, which contributes to hyperleptinemia, and (b) chronic inflammation, hyperinsulinemia and alterations in the FA profile could be important factors that stimulate leptin synthesis in the adipose tissue (Figure 1).